1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pediatric Specialty

Anonymous board for pediatric specialty reps


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    11
    Views:
    7,124
  2. Anonymous
    Replies:
    7
    Views:
    5,364
  3. anonymous
    Replies:
    0
    Views:
    1,149
  4. Anonymous
    Replies:
    4
    Views:
    5,343
  5. Anonymous
    Replies:
    122
    Views:
    44,416
  6. anonymous
    Replies:
    0
    Views:
    1,702
  7. Anonymous
    Replies:
    0
    Views:
    2,591
  8. Anonymous
    Replies:
    392
    Views:
    62,599
  9. Anonymous
    Replies:
    0
    Views:
    2,299
  10. Anonymous
    Replies:
    2
    Views:
    2,657

Thread Display Options

Loading...